Move Better Therapy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Move Better Therapy
Largest movements
- Tangible fixed assets -€21,400
no longer reported in 2024 (was €21,400)
- Cash +€3,685
up €3,685 (+482%), from €764 to €4,449
mainly Investment in fixed assets (net) (+€21,400) and Tax, wage and social debts (+€1,163)
- Receivables within one year +€1,486
up €1,486 (+22.2%), from €6,689 to €8,175
of which Trade receivables: +€2,745
- Other debts -€11,223
down €11,223 (-32.6%), from €34,418 to €23,195
- Profit (loss) carried forward -€4,614
down €4,614 (-45.6%), from -€10,120 to -€14,734
- Trade debts -€1,556
no longer reported in 2024 (was €1,556)
- Tax, wage and social debts +€1,163
new in 2024: €1,163
- Gross operating margin +€24,096
up €24,096, from -€1,771 to €22,325
- Depreciation -€7,119
no longer reported in 2024 (was €7,119)
- Other operating charges +€1,434
up €1,434 (+137%), from €1,050 to €2,484
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €28,854 | €12,625 | -€16,229 | -56.2% |
| Fixed assets | 21/28 | €21,400 | - | -€21,400 | |
| Tangible fixed assets | 22/27 | €21,400 | - | -€21,400 | |
| Plant, machinery and equipment | 23 | €21,400 | - | -€21,400 | |
| Current assets | 29/58 | €7,453 | €12,625 | +€5,171 | +69.4% |
| Amounts receivable within one year | 40/41 | €6,689 | €8,175 | +€1,486 | +22.2% |
| Trade receivables | 40 | €1,972 | €4,717 | +€2,745 | +139% |
| Other amounts receivable | 41 | €4,718 | €3,459 | -€1,259 | -26.7% |
| Cash at bank and in hand | 54/58 | €764 | €4,449 | +€3,685 | +482% |
| Total equity and liabilities | 10/49 | €28,854 | €12,625 | -€16,229 | -56.2% |
| Equity | 10/15 | -€7,120 | -€11,734 | -€4,614 | -64.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€10,120 | -€14,734 | -€4,614 | -45.6% |
| Amounts payable | 17/49 | €35,974 | €24,358 | -€11,615 | -32.3% |
| Amounts payable within one year | 42/48 | €35,974 | €24,358 | -€11,615 | -32.3% |
| Trade debts | 44 | €1,556 | - | -€1,556 | |
| Suppliers | 440/4 | €1,556 | - | -€1,556 | |
| Taxes, remuneration and social security | 45 | - | €1,163 | +€1,163 | |
| Taxes | 450/3 | - | €1,163 | +€1,163 | |
| Other amounts payable | 47/48 | €34,418 | €23,195 | -€11,223 | -32.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,119 | - | -€7,119 | |
| Other operating charges | 640/8 | €1,050 | €2,484 | +€1,434 | +137% |
| Non-recurring operating charges | 66A | - | €24,356 | +€24,356 | |
| Gross operating margin | 9900 | -€1,771 | €22,325 | +€24,096 | |
| Operating profit (loss) | 9901 | -€9,939 | -€4,515 | +€5,424 | +54.6% |
| Financial income | 75/76B | €21 | €1 | -€20 | -95.9% |
| Recurring financial income | 75 | €21 | €1 | -€20 | -95.9% |
| Financial charges | 65/66B | €202 | €100 | -€102 | -50.6% |
| Recurring financial charges | 65 | €202 | €100 | -€102 | -50.6% |
| Profit (loss) for the period before taxes | 9903 | -€10,120 | -€4,614 | +€5,506 | +54.4% |
| Profit (loss) for the period | 9904 | -€10,120 | -€4,614 | +€5,506 | +54.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,120 | -€4,614 | +€5,506 | +54.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.